Neuroem Therapeutics Inc - AZ Maricopa, Scottsdale 85258

Neuroem Therapeutics Inc entered the industry of Neurological Laboratory in 2013 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 621511, which describes it as a Neurological Laboratory. For further clarification, the SIC classifies this business under the code 8071 and described it as a Neurological Laboratory. The business provides service to the B2C market.

To acquire more information, please contact Jon Mcgarity by calling (480) 483-6380 during business hours. You can also write to the business’ Single Location at 9940 North 78th Place, Scottsdale, Arizona AZ 85258. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Neuroem Therapeutics Inc
Representative: Jon Mcgarity
Place of Business: 9940 North 78th Place, Scottsdale, AZ 85258
Contact Number: (480) 483-6380
Type of Service: Neurological Laboratory
SIC Number: 8071
NAICS Number: 621511
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 2013
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Neuroem Therapeutics Inc is a company operating from Maricopa, Arizona providing professional Neurological Laboratory and relevant B2C variables. It was founded in 2013 and registered with the SIC code 8071 as Neurological Laboratory, and with the NAICS code 621511 as Neurological Laboratory.

With a current employee count of 1 to 4, Neuroem Therapeutics Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Jon Mcgarity at (480) 483-6380 for related queries, or to locate its Single Location using the coordinates 33.576399,-111.91266.

The Single Location can also be found at the street address 9940 North 78th Place in Scottsdale, Arizona 85258 and can be engaged online through the company website at , the company Twitter , and Facebook page .